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A B S T R A C T  
Objective: Shivering is a common problem during anesthesia. Ketamine has been used for preventing shivering during 
anesthesia. Ondansetron (8 mg) has been recently evaluated for its peri-operative anti-shivering effect in patients 
undergoing spinal anesthesia. The objective of my study is to compare low dose Ondansetron with low dose Ketamine 
among patients undergoing spinal anesthesia in elective surgery in terms of frequency of shivering. 
Patients and Methods: Patients undergoing elective general surgical procedures at Department of Anesthesiology, 
Holy Family Hospital, Rawalpindi, were inducted in the study. The study design was a randomized control trial and 
conducted from Jan 2016 to June 2016. Patients were included through a consecutive non-probability sampling. After 
spinal anaesthesia, patients were randomly assigned to receive Ketamine 0.25 mg/kg (group A) or Ondansetron 4mg 
(group B) by lottery method. During surgery, shivering was recorded at 10 min interval and recorded in terms of 
frequency. 
Results: Out of the total 256 study participants, 128 patients in each group received the study drug (Ondansetron/ 
Ketamine) before surgery for prevention of shivering. Overall, there were 158 male and 98 female patients. The mean 
age of study population was 36 ± 11 yrs (range 21–40 yrs). Shivering occurred in 11 (4.3%) patients only. There was no 
significant difference between the gender distributions between the two groups (p=0.16). Patients pre-treated with 
Ketamine significantly experienced lesser shivering episodes than Ondansetron group (2 (1.6%) vs. 9 (7%), p=0.03). 
Conclusion: The findings of our study suggest that the prophylactic administration of low dose Ketamine (0.25 mg kg-1) 
and Ondansetron (4mg) produces anti-shivering effect in patients undergoing spinal anaesthesia. Ketamine (0.25 mg/kg) 
is significantly more effective than Ondansetron (4mg) during spinal anaesthesia. 
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I n t r o d u c t i o n  
 
Shivering is very unpleasant, physiologically stressful for 
the patient after surgery, and some patients feel the 
accompanying cold sensation to be worse than the 
surgical pain. Though the mechanism of origin of 
shivering is not clear, various hypotheses have been 
proposed to explain its occurrence.1 Shivering occurs as a 
thermoregulatory response to hypothermia or muscle 
activity with tonic or clonic patterns, and various 
frequencies have been noticed. However, in the 
postoperative period, muscle activity may be increased 
even with normothermia, suggesting that mechanisms 
other than heat loss with subsequent decrease in the core 
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temperature contribute to the origin of shivering. These 
may be uninhibited spinal reflexes, sympathetic over-
activity, postoperative pain, adrenal suppression, pyrogen 
release and respiratory alkalosis.2 
Post Anesthesia Shivering (PAS) occurs in 40% of 
patients recovering from spinal anesthesia. Most of the 
times, it is preceded by central hypothermia and 
peripheral vasoconstriction indicating that it is almost 
always thermoregulatory mechanism, which even today is 
ill understood. Some shivering may not be 
thermoregulatory, thus making the management of PAS 
complex. The prime objective of this study was to 
understand physiology of PAS, organization of the 
thermoregulatory mechanism, and various measures for 
its prevention3. Shivering is an involuntary, repetitive 
activity of skeletal muscles mainly caused by 
intraoperative heat loss, increased sympathetic tone, 
pain, and systemic release of pyrogens. The median 
incidence of shivering related to regional anesthesia 
observed in a review of 21 studies is 55%.4 Shivering 
increases oxygen consumption, lactic acidosis, carbon 
dioxide production, and metabolic rate by up to 
400%. Therefore, shivering may cause problems in 
patients with low cardiac and pulmonary reserves. The 
best way to avoid these intraoperative and postoperative 
shivering-induced increases in hemodynamic and 
metabolic demands is to prevent shivering in the first 
place.4 Post anesthetic shivering may cause discomfort to 
patients, and aggravate wound pain by stretching 
incisions and increase intracranial and intraocular 
pressure. Regional anesthesia produces vasodilatation, 
which facilitates core-to-peripheral redistribution of heat 
and the cool periphery is warmed at the expense of the 
core compartment. Thus, hypothermia from epidural 
anesthesia results from redistribution of heat from the 
core to the periphery.5 Ondansetron, 5-HT3 receptor 
antagonist, is used antiemetic drug. It causes inhibition of 
serotonin reuptake on the pre-optic anterior hypothalamic 
region which might influence both heat production and 
heat loss pathways. Ketamine has sympathomimetic 
activity thus may contribute towards heat preservation 
model and thus prevent shivering. 
Spinal anaesthesia is widely used as a safe anaesthetic 
technique for both elective and emergency operations. 
Shivering is known to be a frequent complication, reported 
in 40 to 70% of patients undergoing surgery under 
regional anaesthesia. Shivering is a potentially serious 
complication, resulting in wound infection; increased 
surgical bleeding; and morbid cardiac events.6 
    P a t i e n t s  a n d  M e t h o d s  
This randomized trial was conducted at Holy Family 
Hospital, Rawalpindi for a period of 6 months from Jan 
2016 to June 2016. A total of 256 elective general 
surgical patients, aged 20-40 years, having mild systemic 
diseases with no functional limitations were included in 
the study by consecutive non-probability sampling 
technique. Patients with concomitant co-morbid conditions 
like diabetes mellitus, hypertension, ischemic heart 
diseases, pulmonary, hepatic or renal diseases diagnosed 
on history and clinical examination were excluded from 
the study.  Similarly, individuals suffering from illnesses in 
which regional anesthesia were contraindicated like 
coagulopathies, infection at injection site, hypovolemia 
and having history of allergic reactions/hypersensitivity for 
using ondansetron and ketamine were not included in the 
study. After taking approval from hospital ethical 
committee, patients were assessed for anaesthesia 
fitness a day before surgery and no oral intake was 
advised for at least 8 hrs before surgery. Written informed 
consent was taken. Patients were randomly divided into 
group A and B of 128 individuals each by lottery method. 
All the patients were given premedication with 0.25mg 
Alprazolam oral tablet at night before surgery. In the 
operating room, routine standard monitoring protocols 
were followed in all patients. The temperature of operating 
room was maintained at 24-26°C with the help of air 
conditioner temperature setting. Before spinal 
anaesthesia, each patient was preloaded with 10-15 ml/kg 
of the Ringer Lactate solution. Subarachnoid block was 
instituted at either L3-L4 interspace with 2 ml of 0.75% 
hyperbaric Bupivacaine in sitting position. Axillary 
temperature was measured with the help of axillary 
thermometer every 20 minutes till end of the surgical 
procedure. 
The intravenous fluid at room temperature (24°C- 26°C) 
was infused and all the patients were covered with 
standard sterile surgical drapes. Just after the intrathecal 
injection, one of the study drugs (Ondansetron 4 mg/ 
Ketamine 0.25 mg/kg) was given as IV bolus. Shivering 
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was measured as significant or not at 10 min interval per-
operatively and recorded in terms of frequency.  
Data was entered and analysed in SPSS (17.0). Mean ± 
standard deviation was calculated for quantitative 
variables like Age & BMI. Frequency and percentages 
were calculated for qualitative variables like gender and 
shivering. Chi- square or Fishers exact test was used to 
compare shivering in both groups. p<0.05 was taken as 
level of significance.  
R e s u l t s  
Out of the total 256 study participants, 158 were male and 
98 were female. Mean age of study population was 
approximately 36 ± 11yrs (range 21-40yrs) (Table 1). 
 
 Patients were divided into two groups, 128 in each group. 
One group was given Ondansetron and second group 
was provided Ketamine before surgery for prevention of 
shivering.  
There were 58 (36.7%) males in Ketamine group in 
comparison to 100 (63.3%) males in Ondansetron group. 
Similarly, the female proportion in the study patients was 
28.6% in Ondansetron group and 71.4% in Ketamine 
group. The mean Age (yrs) was not significantly different 
between the two groups. Patients pre-treated with 
Ketamine significantly experienced lesser shivering 
episodes than Ondansetron group; 2 (18.2%) vs. 9 
(81.8%), p=0.03 (Table 2). 
D i s c u s s i o n  
Very few studies are available till date in relation to use of 
ketamine for prevention of shivering during general or 
regional anaesthesia probably because of its undesirable 
side effects like too much sedation, hallucination, nausea 
and vomiting. 10 In our study, very low dose of ketamine 
(0.25mg/kg) was used to minimize the side effect and we 
found that it was significantly effective and the shivering 
was observed only in 2 patients out of 40 (1.6%). In one 
study Dal et al. compared placebo, meperidine and 
ketamine 0.5 mg/kg for prevention of shivering after 
general anesthesia and found ketamine 0.5 mg/kg to be 
effective.8 Although our study was performed on the 
patients to observe incidence of shivering after 
prophylactic use of ketamine during spinal anesthesia as 
compared to patients undergoing general anesthesia in 
Dal et al. study, our study is better because: first, a lower 
dose of ketamine (0.25 mg/kg) was used as compared to 
0.5 mg/kg ketamine. In addition, in comparison to 30 
patients who were given ketamine in this study we gave 
ketamine to 128 study participants. Shivering was graded 
using a scale that was validated by Gangopadhyay S et 
al.9 The prophylactic drug was considered ineffective if 
the patient shivered to grade 3 and pethidine 0.5mg kg-1IV 
was given to control the shivering. Sagir et al 10 and 
Shakya et al 7 used same protocol in their study. 
Ondansetron, which is a specific 5-HT3 receptor 
antagonist, influence both heat production and heat loss 
pathways.11 The recommended dose of Ondansetron for 
prevention of postoperative nausea & vomiting is 4-8 mg 
in adult patients.12 Kelsaka et al13 compared the 8mg 
Ondansetron with Pethidine for prevention of shivering 
and found the same anti-shivering effect and the 
incidence of shivering was 8% in Ondansetron group. In 
study by Shakya et al 7, low dose of Ondansetron (4mg) 
was used and the incidence of shivering was only 10% in 
the Ondansetron group. In our study, shivering occurred 
in almost same frequency as given in literature i.e. 7% 
patients pre-medicated with Ondansetron in a dose of 
4mg. 
In present study, despite a higher age group in Ketamine 
treated patients, when the effectiveness of Ondansetron 
and Ketamine was compared, Ketamine was found to be 
more effective in prevention of shivering. 9 (7%) vs. 2 
(1.6%), p=0.03). The side effects of the drugs, which 
Table 1: Baseline characteristics of study population 
Total patients (n) 256 
Patients in each group (n) 128 
Gender;  
n (%) 
Males 158(61.72) 
Females 98(38.28) 
Age (years); Mean±SD 36 ± 11 (Range 21-40) 
Shivering Frequency; n (%) 11 (4.3) 
Table 2: Comparison of pre-operative Ketamine and 
Ondansetron in prevention of post-operative shivering 
(n=256) 
Variables Ketamine 
(n=128) 
Ondansetron 
(n=128) 
p-
value 
Gender; 
 n (%) 
Males 58 (36.7) 100 (63.3) 0.16 
Females 70 (71.4) 28 (28.6) 
Mean Age (years); 
mean ± SD 
30.02 ± 
05.54 
29.93 ± 
05.80 
0.9 
Shivering; 
n (%) 
Present 2 (18.2) 9 (81.8) 0.004 
Absent 126 
(51.4) 
119 (48.6) 
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although are not part of our study objectives, were also no 
more in Ketamine group as expected from its known 
pharmacologic properties. 
C o n c l u s i o n  
The findings of our study suggest that the prophylactic 
administration of low dose Ketamine (0.25 mg kg-1) and 
Ondansetron (4mg) produces anti-shivering effect in 
patients undergoing spinal anaesthesia. Ketamine (0.25 
mg/kg) is significantly more effective than Ondansetron 
(4mg) during spinal anaesthesia. 
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